The senior VP of Global Health Economics and Outcomes Research and Epidemiology at Biohaven Pharmaceuticals discussed the findings from a poster presentation on the economic impact of migraine disability at AHS 2020.
Gilbert L'Italien, PhD
Advertisement
Articles by Gilbert L'Italien, PhD
Advertisement
Latest Updated Articles
Gilbert L'Italien, PhD: The Economic Impact of MIDAS Disability Grades in MigrainePublished: June 20th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
2
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
3
Ocrelizumab’s Encouraging Treatment Effects Across Conception Delivery and Breastfeeding
4
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
5
